Anika Therapeutics, Inc. (ANIK) - Product Pipeline Analysis, 2015 Update

Date: May 19, 2015
Pages: 43
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A05669E5E25EN
Leaflet:

Download PDF Leaflet

Anika Therapeutics, Inc. (ANIK) - Product Pipeline Analysis, 2015 Update
Summary

Anika Therapeutics, Inc. (Anika) is a medical technology company which develops, manufactures, and markets therapeutic products for tissue protection, healing, and repair. It offers solutions for orthobiologics, dermal, surgical and veterinary applications. Some of its major products include non-animal sourced viscosupplements, advanced wound care devices, anti-adhesion gels, dental bone grafting adjuncts and joint dysfunction management fluids for horses, among others. Its products are made from hyaluronic acid (HA) based on two technologies: HYAFF, which is a solid form of HA, and ACP gel, an autocross-linked polymer of HA. Anika has research and manufacturing facilities in Bedford and Woburn in Massachusetts. It operates in the US, Europe and other countries. Anika is headquartered in Massachusetts, the US.Anika seeks to enter into long-term collaborations with industry leaders, to deliver new therapeutic products and to advance healthcare opportunities for the customers.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Anika Therapeutics, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Anika Therapeutics, Inc. Company Snapshot
Anika Therapeutics, Inc. Company Overview
Key Information
Anika Therapeutics, Inc. Pipeline Products and Clinical Trials Overview
Anika Therapeutics, Inc. – Pipeline Analysis Overview
Business Description
Key Facts
Anika Therapeutics, Inc. - Major Products and Services
Anika Therapeutics, Inc. Pipeline Products by Development Stage
Anika Therapeutics, Inc. Clinical Trials by Trial Status
Anika Therapeutics, Inc. Pipeline Products Overview
Cingal
Cingal Product Overview
Cingal Clinical Trial
Hemostatic Patch
Hemostatic Patch Product Overview
HYAFF Barrier Film
HYAFF Barrier Film Product Overview
HYAFF Gel
HYAFF Gel Product Overview
HYAFF Mesh
HYAFF Mesh Product Overview
HYAFF/ACP Spray - Adhesion
HYAFF/ACP Spray - Adhesion Product Overview
Hyalobone
Hyalobone Product Overview
Hyalofast
Hyalofast Product Overview
Hyaloglide
Hyaloglide Product Overview
Hyalonect
Hyalonect Product Overview
Hyalospine
Hyalospine Product Overview

INCERT-S

INCERT-S Product Overview
Next Generation ELEVESS Dermal Filler
Next Generation ELEVESS Dermal Filler Product Overview
Anika Therapeutics, Inc. - Key Competitors
Anika Therapeutics, Inc. - Key Employees
Anika Therapeutics, Inc. - Key Employee Biographies
Anika Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Anika Therapeutics, Inc., Recent Developments
Apr 28, 2015: Anika Therapeutics Reports First-Quarter 2015 Financial Results
Apr 28, 2015: Anika Therapeutics Announces Presentation of Seven Abstracts at 12th Annual World Congress of the International Cartilage Repair Society
Apr 17, 2015: Anika Therapeutics Reports on Cingal 13-01 Study Clinical Trial Top Line Data and Announces the Completion of Cingal 13-02 Study’s Patient Enrollment
Apr 10, 2015: Hyalomatrix Receives CMS Reimbursement Coverage in 11 States
Apr 08, 2015: Anika Therapeutics Files IDE Application with U.S. FDA for Hyalofast
Feb 25, 2015: Anika Therapeutics Reports Fourth-Quarter and Full-Year 2014 Financial Results
Feb 19, 2015: Anika Therapeutics Appoints Dr. Glenn Larsen to its Board of Directors
Feb 11, 2015: Anika Therapeutics Announces Regulatory Submissions with U.S. FDA and European Regulatory Authorities for Cingal
Nov 10, 2014: Center for Medicare & Medicaid Services Announces That a Unique Reimbursement Code is Assigned to Anika’s MONOVISC Product
Oct 29, 2014: Anika Therapeutics Reports Third-Quarter 2014 Financial Results
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES
Anika Therapeutics, Inc., Key Facts
Anika Therapeutics, Inc. Pipeline Products and Clinical Trials Overview
Anika Therapeutics, Inc. Pipeline Products by Equipment Type
Anika Therapeutics, Inc. Pipeline Products by Indication
Anika Therapeutics, Inc. Clinical Trials by Trial Status
Anika Therapeutics, Inc., Key Facts
Anika Therapeutics, Inc., Major Products and Services
Anika Therapeutics, Inc. Number of Pipeline Products by Development Stage
Anika Therapeutics, Inc. Pipeline Products Summary by Development Stage
Anika Therapeutics, Inc. Clinical Trials by Trial Status
Anika Therapeutics, Inc. Clinical Trials Summary
Cingal - Product Status
Cingal - Product Description
Cingal - To Evaluate the Safety of a Repeat Injection of Cross-linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee (Cingal 13-02: An Open-label, Follow-on Study to Cingal 13-01)
Hemostatic Patch - Product Status
Hemostatic Patch - Product Description
HYAFF Barrier Film - Product Status
HYAFF Barrier Film - Product Description
HYAFF Gel - Product Status
HYAFF Gel - Product Description
HYAFF Mesh - Product Status
HYAFF Mesh - Product Description
HYAFF/ACP Spray - Adhesion - Product Status
HYAFF/ACP Spray - Adhesion - Product Description
Hyalobone - Product Status
Hyalobone - Product Description
Hyalofast - Product Status
Hyalofast - Product Description
Hyaloglide - Product Status
Hyaloglide - Product Description
Hyalonect - Product Status
Hyalonect - Product Description
Hyalospine - Product Status
Hyalospine - Product Description
INCERT-S - Product Status
INCERT-S - Product Description
Next Generation ELEVESS Dermal Filler - Product Status
Next Generation ELEVESS Dermal Filler - Product Description
Anika Therapeutics, Inc., Key Employees
Anika Therapeutics, Inc., Key Employee Biographies
Anika Therapeutics, Inc., Other Locations
Anika Therapeutics, Inc., Subsidiaries

LIST OF FIGURES
Anika Therapeutics, Inc. Pipeline Products by Equipment Type
Anika Therapeutics, Inc. Pipeline Products by Development Stage
Anika Therapeutics, Inc. Clinical Trials by Trial Status
Skip to top


Ask Your Question

Anika Therapeutics, Inc. (ANIK) - Product Pipeline Analysis, 2015 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: